The cold plunging phenomenon continues to reshape the $1.8 trillion global wellness economy as consumers trade traditional spa treatments for extreme temperature therapy. What began as niche athletic recovery has migrated into mainstream health routines, with home installation units now retailing between $5,000 and $30,000. Manufacturers report order backlogs stretching into 2025, while gym chains including Equinox and Lifetime Fitness have added plunge pools to flagship locations to justify premium membership tiers.

Investor attention has followed consumer adoption. Venture capital flowed into at least six cold-therapy startups in the past 18 months, valuing the largest at roughly $200 million. Publicly traded pool and spa companies have cited cold-plunge accessories as a rare growth segment amid flat hot-tub sales. The trend also fuels adjacent markets: breathwork apps, contrast-therapy programming, and wearable devices that track heart-rate variability during immersion.

Regulatory scrutiny is minimal — the FDA classifies most units as general wellness devices — but insurers have begun asking whether repeated extreme cold exposure poses cardiovascular risks for untrained users. That question could determine whether employer wellness budgets cover plunge sessions or restrict them to high-deductible health plans.